Ajay Piramal Quotes

The investor of today does not profit from yesterday's growth.

Chasing revenues that don't have good earnings doesn't help us or shareholders one lick.

You can be far more aggressive when you're making good profits.

Zeroing in on the best sectors or the best regions of the world is great, but zeroing in on the very best individual stocks is the key to making truly impressive profits.

Because publishing is becoming more business-oriented each day with more examination of the bottom line, it's harder to break out than ever.

When a company is fairly certain of a profit margin that is substantial, it can assume responsibility for the clinical trials to develop a blockbuster drug.

I don't want to do business with those who don't make a profit, because they can't give the best service.

We're certainly interested in maximizing our return and doing it - we're interested in maximizing our return, but we're also interested in doing it over a long period of time and in doing it in a way that never endangers the firm from a survivability standpoint.

For Gazprom, 2015 is turning out auspiciously. We already see the possibility for additional investments in our investment program.

I think they quite like me when I work because I'm one of the safer directors to back, because even if my films don't bring their costs in back home, once they're shown outside of India they manage to cover the costs.

I've been investing in the stock market for 27 years and, within that time, have helped investors beat the market nearly four to one.

When buying shares, ask yourself, would you buy the whole company?

I've had such a great track record in making a huge profit when the movies are smaller.

It’s our tax dollars that fund the initial research for these molecules that get transferred to corporations. We have an investment here… We end up paying for our drugs twice. We pay for the initial development through our tax dollars. And then when it goes on the market we pay their inflated prices.

The disciplined approach to pursuing and selecting the most attractive investment opportunities continues to distinguish ExxonMobil. We are long-term driven, and we're patient. And we're not opportunity-constrained.

Returns matter a lot. It's our capital.

Financial risk is always associated with drug discovery. But the benefit that a blockbuster drug can bring to the business can be phenomenal if you can take that risk.

We're only going to invest our shareholders' money where we think they can get the kind of returns they expected when they invested their money with Exxon Mobil.

When we do acquisitions, we decide what we want. We decide what fills a hole. And if the price is too high, our alternative is the $5 billion we spend on R&D every year. We're not well-known for overpaying, because at Oracle we always have an alternative.

I never heard of anyone saying they want to deploy their capital wisely and go buy a sports franchise. What you want to do is just not lose money. You see, I don't have to work anymore. I tell people I don't have a real job. On the other hand, I learned long ago that you can't go broke if you turn a profit.

To ensure that America remains the leader in medical innovation, we must reduce the costs of developing life-saving drugs and ensure that there are appropriate economic incentives in place to produce them.

Well, there's always risk in long-term investment.

We have an obligation to provide a return for our shareholders.

I may believe in something, but if it is not working and is not giving returns, we have to close it down because that is the right thing to do for the shareholders.

I'm happy to make returns of 4% to 6% a year on my real estate portfolio. If inflation comes along I'll be able to increase rent and have capital appreciation roughly in line with inflation.